Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Atara Biotherapeutics

Clinical trials sponsored by Atara Biotherapeutics, explained in plain language.

Atara Biotherapeutics ATRA NASDAQ

A cell therapy company developing off-the-shelf T-cell immunotherapies.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Experimental donor CAR-T therapy tested in lymphoma – trial halted early

Disease control Terminated

This early-phase trial tested a new therapy called ATA3219, which uses immune cells from a healthy donor to attack cancer cells in people with relapsed or refractory B-cell non-Hodgkin lymphoma. The study aimed to check safety and see if the treatment works, but it was stopped ea…

Phase: PHASE1 • Sponsor: Atara Biotherapeutics • Aim: Disease control

Last updated Jun 27, 2026 11:00 UTC